ACA
SNY icon

Aptus Capital Advisors’s Sanofi SNY Stock Holding History

Aptus Capital Advisors’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,761
Closed -$230K – 1653
2025
Q2 		$230K Buy
4,761
+1,088
+30% +$55.6K ﹤0.01% 901
2025
Q1 		$204K Buy
+3,673
New +$199K ﹤0.01% 887
2024
Q4 		– Sell
-3,792
Closed -$219K – 1455
2024
Q3 		$219K Sell
3,792
-426
-10% -$23K ﹤0.01% 739
2024
Q2 		$205K Buy
+4,218
New +$203K ﹤0.01% 731
2019
Q2 		– Sell
-4,790
Closed -$212K – 361
2019
Q1 		$212K Buy
+4,790
New +$205K 0.04% 294

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Aptus Capital Advisors's SNY Position: Q3 2025 in Review

Aptus Capital Advisors sold out of Sanofi (SNY) in Q3 2025, closing a stake of 4,761 shares — an estimated $230K sold.

Aptus Capital Advisors first reported a position in SNY in Q1 2019 and held it in 5 quarters. The position peaked at $230K in Q2 2025. 710 funds tracked by Wall St. Rank hold SNY as of Q3 2025.

  • Aptus Capital Advisors reported no remaining Sanofi position as of Q3 2025 after selling out during the quarter.
  • Aptus Capital Advisors sold 4,761 Sanofi shares in Q3 2025, an estimated $230K.
  • Aptus Capital Advisors first reported a position in Sanofi in Q1 2019 and held it in 5 quarters.
  • Aptus Capital Advisors's Sanofi position peaked at $230K in Q2 2025.
  • 710 funds tracked by Wall St. Rank held Sanofi as of Q3 2025.

Based on Aptus Capital Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.